(19)
(11) EP 1 865 870 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
04.04.2012 Bulletin 2012/14

(45) Mention of the grant of the patent:
25.01.2012 Bulletin 2012/04

(21) Application number: 06748830.4

(22) Date of filing: 28.03.2006
(51) International Patent Classification (IPC): 
A61B 18/14(2006.01)
 A61B 5/053(2006.01)
(86) International application number:
PCT/US2006/011341
(87) International publication number:
WO 2006/105121 (05.10.2006 Gazette 2006/40)

(54)

INTRALUMINAL ELECTRICAL TISSUE CHARACTERIZATION AND TUNED RF ENERGY FOR SELECTIVE TREATMENT OF ATHEROMA AND OTHER TARGET TISSUES

INTRALUMINALE ELEKTRISCHE GEWEBECHARAKTERISIERUNG UND ABGESTIMMTE HF-ENERGIE ZUR SELEKTIVEN BEHANDLUNG VON ATHEROM UND ANDEREN ZIELGEWEBEN

CARACTERISATION DE TISSU ELECTRIQUE INTRALUMINAL ET ENERGIE RF ACCORDEE DESTINEE AU TRAITEMENT SELECTIF D'ATHEROME ET D'AUTRES TISSUS CIBLES

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

(30) Priority: 28.03.2005 US 666766 P

(43) Date of publication of application:
19.12.2007 Bulletin 2007/51

(60) Divisional application:
11191822.3

(73) Proprietor: Vessix Vascular, Inc.
Laguna Hills, CA 92653 (US)

(72) Inventors:
  • STONE, Corbett, W.
    San Diego, CA 92191 (US)
  • HOEY, Michael, F.
    San Diego, CA 92191 (US)
  • STEINKE, Tom, A.
    San Diego, CA 92191 (US)
  • MICHEL, Raphael, M.
    San Diego, CA 92191 (US)
  • BLANCK, Arthur, G.
    San Diego, CA 92191 (US)

(74) Representative: Clark, Jane Anne et al
Mathys & Squire LLP 120 Holborn
London EC1N 2SQ
London EC1N 2SQ (GB)


(56) References cited: : 
WO-A-02/058549
US-A- 4 682 596
US-A1- 2003 088 189
 US-A- 4 587 975
US-A- 6 036 689
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).